Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMSP0506AV01 Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1372.81 C66H120N2O27
LMSP0506BC01 Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1696.91 C78H140N2O37
LMSP0506BD07 Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1295.83 C66H121NO23
LMSP0506BB04 Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1618.95 C78H142N2O32
LMSP0506AU07 Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1498.91 C74H134N2O28
LMSP0506AU05 Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1500.93 C74H136N2O28
LMSP0506AZ06 Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1309.88 C68H127NO22
LMSP0506AZ03 Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1225.79 C62H115NO22
LMSP0506AO03 GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1485.89 C72H131N3O28
LMSP0506AO05 GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1541.95 C76H139N3O28
LMSP0506AO08 GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1567.97 C78H141N3O28
LMSP0506BH02 Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1619.91 C76H137N3O33
LMSP0506BC02 Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1724.94 C80H144N2O37
LMSP0506AJ01 GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1794.96 C82H146N4O38
LMSP0506AO02 GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1457.86 C70H127N3O28
LMSP0506AV08 Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1510.95 C76H138N2O27
LMSP0506BH01 Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1591.88 C74H133N3O33
LMSP0506BG04 GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1513.92 C74H135N3O28
LMSP0506BG01 GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1429.83 C68H123N3O28
LMSP0506AL06 GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1773.07 C86H156N4O33
LMSP0506AH05 GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 2110.17 C98H175N5O43
LMSP0506BA08 Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1689 C82H148N2O33
LMSP0506AP02 Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1254.78 C62H114N2O23
LMSP0506AA08 Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1307.87 C68H125NO22
LMSP0506BG02 GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1457.86 C70H127N3O28
LMSP0506BJ02 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1765.97 C82H147N3O37
LMSP0506BJ01 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1737.94 C80H143N3O37
LMSP0506AN08 Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1526.94 C76H138N2O28
LMSP0506BJ03 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1794 C84H151N3O37
LMSP0506BB01 Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1534.86 C72H130N2O32
LMSP0506AU01 Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1388.8 C66H120N2O28
LMSP0506AI03 GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1851.02 C86H154N4O38
LMSP0506AK03 GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1647.94 C78H141N3O33
LMSP0506BD05 Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1297.85 C66H123NO23
LMSP0506BF08 Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1364.89 C70H128N2O23
LMSP0506AU06 Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1528.96 C76H140N2O28
LMSP0506BF03 Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1282.81 C64H118N2O23
LMSP0506AJ07 GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1905.07 C90H160N4O38
LMSP0506AI08 GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1933.1 C92H164N4O38
LMSP0506BJ05 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1850.07 C88H159N3O37
LMSP0506AL04 GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1717 C82H148N4O33
LMSP0506AO06 GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1569.99 C78H143N3O28
LMSP0506AA03 Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1225.79 C62H115NO22
LMSP0506AH03 GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 2054.1 C94H167N5O43
LMSP0506AJ04 GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1879.06 C88H158N4O38
LMSP0506AH07 GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 2108.15 C98H173N5O43
LMSP0506BC04 Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1781.01 C84H152N2O37
LMSP0506AH04 GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 2082.13 C96H171N5O43
LMSP0506BI02 Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1603.92 C76H137N3O32
LMSP0506AP03 Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1282.81 C64H118N2O23